Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Minoxidil and finasteride effectively treat hair loss.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Fetal skin heals without scarring due to unique cells and processes not present in adult skin healing.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Fetal wounds heal without scarring because of different biological factors, which could help improve adult wound healing.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The protein CCN2 controls hair growth by affecting hair follicle formation and stem cell activity in mice.

miR-140-5p in certain cell vesicles helps hair growth by boosting cell proliferation.

ROR2 is essential for hair follicle stem cell renewal and maintenance.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.